Effect of Xolair on Airway Hyperresponsiveness

NCT00208234 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Allergic Asthma

Interventions

DRUG: Omalizumab
DRUG: Placebo for Omalizumab
DRUG: omalizumab

Sponsor

Creighton University

Collaborators

[object Object]